Skip to main content

Tango Therapeutics, Inc 10-K for FY2025

Tango Therapeutics, Inc. (TNGX)

10-K 2026-03-05 For: 2025-12-31
View Original
Added on April 08, 2026

About this 10-K

Tango Therapeutics, Inc filed this 10-K on March 5, 2026, covering the fiscal year ended December 31, 2025 (FY2025).

Headline figures

Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$62.38M
up 48.3% from $42.07M a year earlier
Net loss
$101.59M
compared with a net loss of $130.3M a year earlier
Diluted EPS
-$0.87
compared with -$1.19 a year earlier